Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
Sponsor: Azienda USL Reggio Emilia - IRCCS · NCT06749600 on ClinicalTrials.gov ↗
Conditions studied
Where it's running10 sites
10 international sites
- Recruiting now
AOU Policlinico di Modena
Modena, Italy, Italy 41125
- Cinzia Baldessari, MD(contact)[email protected]
- Cinzia Baldessari, MD(principal investigator)
- Recruiting now
Azienda Ospedaliero Universitaria di Parma - S.C. Ostetricia e Ginecologia
Parma, PR, Italy 43126
- Roberto Berretta, MD(contact)+390521704068[email protected]
- Roberto Berretta, MD(principal investigator)
- Recruiting now
Azienda USL IRCCS di Reggio Emilia
Reggio Emilia, RE, Italy 42123
- Jasmine Lonetti, Clinical Research Coordinator(contact)+39 0522295467[email protected]
- Vincenzo Mandato(principal investigator)
- Recruiting now
Malzoni - Avellino
Avellino, Italy 83100
- Francesca Falcone, MD(contact)+39 0825 25596[email protected]
- Francesca Falcone, MD(principal investigator)
- Recruiting now
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" - Catania
Catania, Italy 95123
- Liliana Mereu, MD(contact)+39 095 479 4111[email protected]
- Liliana Mereu, MD(principal investigator)
- Recruiting now
IRCCS Ospedale San Raffaele
Milan, Italy 20132
- Raffaella Cioffi, MD PhD(contact)02 2643 4880[email protected]
- Raffaella Cioffi, MD PhD(principal investigator)
- Recruiting now
Fondazione Irccs San Gerardo Dei Tintori
Monza, Italy
- Tommaso Grassi, MD(contact)039 2331[email protected]
- Tommaso Grassi(principal investigator)
- Recruiting now
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Naples, Italy 80131
- Jole Ventriglia, MD(contact)+39 081 17770468[email protected]
- Jole Ventriglia, MD(principal investigator)
- Recruiting now
Università degli Studi di Napoli Federico II
Naples, Italy
- Roberto Bianco, MD PhD(contact)081-7462061[email protected]
- Roberto Bianco, MD PhD(principal investigator)
- Recruiting now
Ospedale "Sacro Cuore"
Verona, Italy
- Giovanni Roviglione, MD(contact)0456014581[email protected]
- Giovanni Roviglione, MD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Diagnosis of primary leiomyosarcoma of the ovary; * Patients diagnosed with POLMS for whom data relating to diagnosis and treatment are available. * Aged between 18 and 99 years Exclusion Criteria: \- All patients with other forms of ovarian sarcoma (rhabdomyosarcomas, fibrosarcomas, stromal cell sarcomas) and patients diagnosed with leiomyosarcoma of the uterus will be excluded.
Updated 2026-05-05 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.